Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 2Short Bowel Syndrome 1Esophageal Squamous Cell Carcinoma 1Diarrhea 1Colorectal Neoplasms 1Colonic Neoplasms 1Colitis, Ulcerative 1Carcinoma, Non-Small-Cell Lung 1

Interventions

etrolizumab 5Adalimumab 2Ringer's Lactate 1Mesalamine 1Loperamide 1Injections 1Infliximab 1Hydroxyethyl Starch Derivatives 1Andrographis paniculata extract 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Colitis, Ulcerative × Loperamide × Clear all
NCT02266849 2016-10-11

Loperamide vs. Placebo's Effect on Ileostomy Output: A Clinical Randomized Blinded Cross-over Study

Odense University Hospital

Phase 3 Terminated
12 enrolled
Gastrointestinal

Colitis, Ulcerative, Rectal Neoplasms, Short Bowel Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡